Volume 10 (2012): Issue 11 (Nov 2012)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xvi–xvii
Oncology Research Program
Pages: xxvi–xxvii
A “Shot Heard ’Round the World” on Cancer Drug Costs?
By: Harold J. Burstein
Pages: 1315–1316
The Oncologist’s Impact on Drug Choices
By: George N. Whitelaw, Kay E. Jewell, and Nevin Whitelaw
Pages: 1318–1321
Lung Cancer Screening: The Last 10 Years
By: Douglas E. Wood
Pages: 1323–1325
Successful Resection After Neoadjuvant Therapy in Pancreatic Adenocarcinoma
By: Parvin F. Peddi and Andrea Wang-Gillam
Pages: 1330–1334
Ovarian Cancer, Version 3.2012
By: Robert J. Morgan, Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Mariana Castells, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O’Malley, Richard T. Penson, Steven W. Remmenga, Paul Sabbatini, Joseph T. Santoso, Russell J. Schilder, Julian Schink, Nelson Teng, Theresa L. Werner, Miranda Hughes, and Mary A. Dwyer
Pages: 1339–1349
Update on Emerging Technologies in Breast Imaging
By: Stephanie K. Patterson and Mitra Noroozian
Pages: 1355–1362
Point: Treating Stage II Colon Cancer: The Quest for Personalized Adjuvant Care
By: Maxwell T. Vergo and Al B. Benson III
Pages: 1370–1374
Counterpoint: Adjuvant Therapy in Stage II Colon Cancer: Pain Not Justified by the Gain
By: Katherine Van Loon and Alan P. Venook
Pages: 1379–1386
A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m2 for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
By: Matthew G. Fury, Eric Sherman, Donna Lisa, Neeraj Agarwal, Kenneth Algazy, Bruce Brockstein, Corey Langer, Dean Lim, Ranee Mehra, Sandeep K. Rajan, Susan Korte, Brynna Lipson, Furhan Yunus, Tawee Tanvetyanon, Stephanie Smith-Marrone, Kenneth Ng, Han Xiao, Sofia Haque, and David G. Pfister
Pages: 1391–1398
New Agents in Metastatic Prostate Cancer
By: Atish D. Choudhury and Philip W. Kantoff
Pages: 1403–1409
Prevention and Treatment of Cancer-Related Infections
By: Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R. Dubberke, Alison G. Freifeld, Ramiro Garzon, John N. Greene, John P. Greer, James I. Ito, Judith E. Karp, Daniel R. Kaul, Earl King, Emily Mackler, Kieren A. Marr, Jose G. Montoya, Ashley Morris-Engemann, Peter G. Pappas, Ken Rolston, Brahm Segal, Susan K. Seo, Sankar Swaminathan, Maoko Naganuma, and Dorothy A. Shead
Pages: 1412–1445
Current Issues in Vaccines for Adult Patients With Hematologic Malignancies
By: Nicolas C. Issa and Lindsey R. Baden
Pages: 1447–1454
BRAF Mutations in Colorectal Cancer: Clinical Relevance and Role in Targeted Therapy
By: Rona Yaeger and Leonard Saltz
Pages: 1456–1458
  • Collapse
  • Expand